Novelos Therapeutics, Inc. (NVLT) Provides Product Pipeline Update
5/17/2013 8:55:58 AM
More...
|
Novelos Therapeutics, Inc. (NVLT) Closes $5.5 Million Public Offering
2/21/2013 10:10:15 AM
More...
|
Novelos Therapeutics, Inc. (NVLT) Prices $5.5 Million Public Offering
2/13/2013 1:11:36 PM
More...
|
Novelos Therapeutics, Inc. (NVLT) to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 11
2/4/2013 6:50:50 AM
More...
|
Novelos Therapeutics, Inc. (NVLT) Presents Diapeutic Technology Platform at EMIT: Targeted Radiotherapy International Conference
1/31/2013 8:53:42 AM
More...
|
Novelos Therapeutics, Inc. (NVLT) to Present at the Benchmark 2012 Micro Cap Discovery Investor Conference on November 29
11/27/2012 9:38:36 AM
More...
|
Novelos Therapeutics, Inc. (NVLT) Closes $2 Million Private Placement
11/5/2012 12:20:50 PM
More...
|
Novelos Therapeutics, Inc. (NVLT) Announces Enrollment of First Patient in Solid Tumor Imaging Trial With I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center
10/25/2012 10:41:21 AM
More...
|
Novelos Therapeutics, Inc. (NVLT) to Present at 11th Annual Biotechnology Industry Organization (BIO) Investor Forum on October 10
10/3/2012 11:43:28 AM
More...
|
Novelos Therapeutics, Inc. (NVLT) and Academic Collaborators Present Diapeutic Technology Platform at Imaging in 2020 Conference
10/3/2012 9:47:46 AM
More...
|
|